2008 BioPacific Conference Agenda
| 8:00 – 9:00am | Registration and Networking |
| 9:00 – 9:05am | Welcome Remarks Leping Li, Ph.D., President-elect of CABS |
| 9:05 – 9:10am | President’s Remarks Naibo Yang, Ph.D., President of CABS |
| Plenary Session, Chaired by Leping Li | |
| 9:10 – 9:20am | Introductory Remarks, Bill Rutter, Ph.D., CEO of Synergenics |
| 9:20 – 10.00am | Regis Kelly, Ph.D., Director of California Institute of Quantitative Biosciences (QB3) |
| 10:00 – 10.40am | Jim Wells, Ph.D., Harry W. and Diana Hind Distinguished, Professor in Pharmaceutical Sciences at UCSF “Drug Discovery at the Challenging Interface” |
| 10:40 – 11:00am | Coffee break & vendor show |
| Innovative Research and Therapeutic Modality, Chaired by Jing-Shan Hu, Ph.D. | |
| 11:00 – 11:30am | Alan Sacks, Ph.D. M.D., Vice President, RNA Therapeutics, Merck Research Laboratories “RNAi-Based Therapeutics: Promise and Challenges” |
| 11:30 – 12:00am | Mark Kay, Ph.D. M.D., Dennis Farrey Family Professor at Stanford University |
| 12:00 – 12:15pm | Presentation by Beijing Alliance of BioBox Outsourcing (ABO) |
| 12:15 – 1:30pm | Lunch |
| 1:00 – 1:30pm | Slide show: 10 years of SAPA-west & C |
| Innovative Research and Therapeutic Modality, Chaired by Shichang Miao, Ph.D. | |
| 1:30 – 2:00pm | Didier Stainier, Ph.D., Professor of Biochemistry and Biophysics at UCSF “Endodermal organ development and regeneration in zebrafish” |
| 2:00 – 2:30pm | Mark Gallop, Ph.D. Co-Founder & Sr. Vice President of Research, Xenoport “Harnessing Nutrient Transport Mechanisms to Optimize Drug Absorption and Disposition in vivo” |
| 3:00 – 3:30pm | Coffee break & vendor show |
| 3:40 – 4:00pm | Michael Zielenziger, Consultant, Monitor Group “China’s Future in Life Sciences: New Drivers of Innovation” |
| New Business Opportunities, Chaired by Tao Huang, Ph.D. J.D., & Liming Yang, Ph.D. | |
| 3:30 – 4:00pm | William Keller, Vice President, Shanghai Zhangjiang Biotech & Pharmaceutical Base Development Co., Ltd |
| 4:00 – 4:20pm | Jing-Shan Hu, Ph.D., Director of Licensing and External Research, (mainland China, Hong Kong, Taiwan) Merck & Co. “Partnership: a Model for Success” |
| 4:20 – 4:50pm | Tom Duley, J.D., Of Counsel, Morgan Lewis & Bockius LLP “Harnessing the Value of IP: Critical Factors in Biotech Transactions” |
| 4:50 – 6:20pm | Satellite meeting in a separate room with ABO of Beijing |
| 4:50 – 7:00pm | Break, dinner, performance shows (Chaired by Min Bao) |
| Special Evening Session on the Future of Biotech and Pharmaceutical Business In China Chaired by Naibo Yang and Leping Li |
|
| 7:00 – 7:20pm | Marietta Wu, M.D., Ph.D., MBA, Vice President, Burrill Co. |
| 7:20 – 7:40pm | Tony Zhang, Ph.D. Managing Director, Site Head, Eli Lily Global Research China “From FIPCo to FIPNet, transformation of Eli Lilly’s Global R&D” |
| 7:40 – 8:00pm | Xiaochuan Wang, Ph.D., CEO of Sundia Meditech “Historic Opportunities” |
| 8:00 – 8:50pm | Panelists also include: Cheng Liu, Ph.D., CEO of Eureka Therapeutics, Tom Duley, J.D., Jing-Shan Hu, Ph.D. Yajun Xu, Ph.D., Vice President of Biology, Chempartners |